Advertisement

Topics

"ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis" Drugs and Medication Database

09:29 EST 17th February 2019 | BioPortfolio

Here are the most relevant "ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis" Drugs and Medications that we have found in our database.

More Information about "ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis" on BioPortfolio

We have published hundreds of ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis news stories on BioPortfolio along with dozens of ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis Clinical Trials and PubMed Articles about ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis Companies in our database. You can also find out about relevant ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis Drugs and Medications on this site too.

Showing "1467 Patients With Relapsing Forms Multiple Sclerosis" Drugs and Medications 1–25 of 52

Probably Relevant

Teriflunomide [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS.  TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Aubagio [genzyme corp.]

These highlights do not include all the information needed to use AUBAGIO safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012

Tecfidera [biogen inc.]

These highlights do not include all the information needed to use TECFIDERA safely and effectively. See full prescribing information for TECFIDERA.TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral useInitial U.S. Approval: 2013

Possibly Relevant

Rebif [emd serono, inc.]

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injectionInitial U.S. Approval: 1996

Plegridy [biogen inc.]

These highlights do not include all the information needed to use PLEGRIDY™ safely and effectively. See full prescribing information for PLEGRIDY.PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous injectionInitial U.S. Approval: 2014

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Avonex [biogen inc.]

These highlights do not include all the information needed to use AVONEX safely and effectively. See full prescribing information for AVONEX.AVONEX (interferon beta-1a) injection, for intramuscular injectionInitial U.S. Approval: 1996

Teriflunomide [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS. TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Betaseron [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON.BETASERON (interferon beta-1b) for injection, for subcutaneous useInitial U.S. Approval: 1993

Mitoxantrone [fresenius kabi usa, llc]

MitoXANTRONE Injection, USP

Ocrevus [genentech, inc.]

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017

Mitoxantrone [hospira, inc.]

MitoXANTRONE Injection, USP (concentrate)

Zinbryta [abbvie]

These highlights do not include all the information needed to use ZINBRYTA safely and effectively. See full prescribing information for ZINBRYTA.ZINBRYTA (daclizumab) injection, for subcutaneous useInitial U.S. Approval: 2016

Ethamolin [qol medical, llc.]

Ethamolin® (Ethanolamine Oleate) Injection, 5%. For Local Intravenous Use OnlyRx only

Mitoxantrone [teva parenteral medicines, inc.]

mitoXANTRONE Injection USP (concentrate)

Lemtrada [genzyme corporation]

These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA (alemtuzumab) injection, for intravenous use Initial U.S. Approval: 2001

Baclofen [lake erie medical dba quality care products llc]

Baclofen 10 MG

Doxycycline hyclate [cadila healthcare limited]

Doxycycline hyclate Tablets

Doxycycline hyclate [zydus pharmaceuticals (usa) inc.]

Doxycycline hyclate Tablets

Ketorolac tromethamine [fresenius kabi usa, llc]

Ketorolac Tromethamine Injection, USP

Ketorolac tromethamine [remedyrepack inc.]

Ketorolac Tromethamine Injection, USP

Ketorolac tromethamine [remedyrepack inc.]

Ketorolac Tromethamine Injection, USP

Ketorolac tromethamine [fresenius kabi usa, llc]

Ketorolac Tromethamine Injection, USP

Ketorolac tromethamine [fresenius kabi usa, llc]

Ketorolac Tromethamine Injection, USP

Ketorolac tromethamine [fresenius kabi usa, llc]

Ketorolac Tromethamine Injection, USP



Advertisement
Quick Search
Advertisement
Advertisement